Schrödinger outlines $218M-$228M 2026 ACV outlook with focus on hosted transition and Bunsen early access release
Schrodinger, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $15.80
-7.9% in 7d after detection
Post-detection moves
1h
—
1d
+2.3%
3d
-2.0%
7d
-7.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS